Halopid 5 mg (Tablet)
Unit Price: ৳ 1.00 (10 x 10: ৳ 100.00)
Strip Price: ৳ 10.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Haloperidol |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Product Title
- Haloperidol Tablets
Categories
- Antipsychotic Medication
- Neuroleptic Drug
- Butyrophenone Derivative
Description
- Haloperidol is an antipsychotic medication used for the management of hyperactivity, agitation, mania, and psychosis. It has neuroleptic and antiemetic properties and may exhibit hypothermic and anorexiant effects. It is available in tablet and injection forms and is used to treat conditions such as schizophrenia, alcoholism, and behavior disorders in children.
Dosage Form
- Tablet
- Injection (Intramuscular or Intravenous)
Dosage Range for Adults
- Moderate symptomatology: 0.5 mg to 3.0 mg 2 to 3 times daily
- Severe symptomatology: 3.0 mg to 5.0 mg 2 to 3 times daily
- Elderly patients: 0.5 mg to 4.5 mg 2 to 3 times daily
- Chronic or Resistant patients: 3.0 mg to 6.0 mg 2 to 3 times daily
- Initial intramuscular or intravenous dose: 2-10 mg, then every 4-8 hours according to response to total maximum 18 mg daily
Recommended Dosage for Children
- 50 microgram per kg body weight for behavior disorders in disturbed and schizophrenic children
Pharmacology
- Butyrophenone derivative with antipsychotic properties
- Effective in management of hyperactivity, agitation, and mania
- Possesses antiemetic properties
- May exhibit hypothermic and anorexiant effects
Indications
- Nervousness
- Anxiety states
- Psychic disorders
- Irritability
- Aggressiveness
- Insomnia
- Trembling
- Gastrointestinal hypermotility
- Digestive disorders
- Tics
- Stuttering
- Psychomotor agitation
- Delusions
- Hallucinations
- Choreatic movements
- Behavior and character disorders in children
- Nausea
- Vomiting
Interaction
- Interference with anticoagulant properties
- Antagonism with epinephrine and sympathomimetic agents
- Reversal of blood pressure lowering effects of adrenergic-blocking agents
- Enhanced CNS effects when used in combination with methyldopa
- Inhibition of metabolization of tricyclic antidepressants
- Impairment of antiparkinson effects of levodopa
Contraindications
- Comatose states and CNS depression due to alcohol or other depressant drugs
- Severe depressive states
- Previous spastic diseases
- Lesions of the basal ganglia
- Parkinson's syndrome, except in dyskinesias due to levodopa treatment
- Sensitivity to haloperidol
- Senile patients with pre-existing Parkinson-like symptoms
Side Effects
- Headache
- Vertigo
- Insomnia
- Drowsiness
- Lethargy
- Stupor
- Confusion
- Restlessness
- Agitation
- Anxiety
- Euphoria
- Exacerbation of psychotic symptoms including hallucinations
- Dry mouth
- Blurred vision
- Urinary retention
- Heartburn
- Nausea
- Vomiting
- Anorexia
- Diarrhea
- Hypersalivation
Pregnancy & Lactation
- Safety for use in pregnancy and lactation has not been established
- Excretion in breast milk
Precautions & Warnings
- Lowering of convulsive threshold
- Triggering of seizures in known epileptics
- Administration cautiously to patients with severe impairment of liver or kidney function
- Caution in patients with pheochromocytoma and conditions predisposing to epilepsy
- Possible potentiating effect on potent analgesics or hypnotics
Overdose Effects
- Exaggeration of known pharmacologic effects and adverse reactions
- Severe extrapyramidal reactions
- Hypotension
- Sedation
- Comatose state with respiratory depression and hypotension
Therapeutic Class
- Butyrophenone drugs
- Drugs used in tremor, tics & related disorders
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of the reach of children